Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

Multimodal optical, X-ray CT, and SPECT imaging of a mouse model of breast cancer lung metastasis.

Davison CA, Chapman SE, Sasser TA, Wathen C, Diener J, Schafer ZT, Leevy WM.

Curr Mol Med. 2013 Mar;13(3):368-76.

PMID:
23331009
2.

Longitudinal Assessment of Lung Cancer Progression in Mice Using the Sodium Iodide Symporter Reporter Gene and SPECT/CT Imaging.

Price DN, McBride AA, Anton M, Kusewitt DF, Norenberg JP, MacKenzie DA, Thompson TA, Muttil P.

PLoS One. 2016 Dec 30;11(12):e0169107. doi: 10.1371/journal.pone.0169107. eCollection 2016.

3.

SPECT/CT of lung nodules using 111In-DOTA-c(RGDfK) in a mouse lung carcinogenesis model.

Hayakawa T, Mutoh M, Imai T, Tsuta K, Yanaka A, Fujii H, Yoshimoto M.

Ann Nucl Med. 2013 Aug;27(7):640-7. doi: 10.1007/s12149-013-0729-1. Epub 2013 Apr 23.

PMID:
23609239
4.

Influence of mesenchymal stem cells on metastasis development in mice in vivo.

Meleshina AV, Cherkasova EI, Shirmanova MV, Klementieva NV, Kiseleva EV, Snopova LВ, Prodanets NN, Zagaynova EV.

Stem Cell Res Ther. 2015 Feb 27;6:15. doi: 10.1186/s13287-015-0003-7.

5.

Bone metastasis imaging with SPECT/CT/MRI: a preclinical toolbox for therapy studies.

Sanches PG, Peters S, Rossin R, Kaijzel EL, Que I, Löwik CW, Grüll H.

Bone. 2015 Jun;75:62-71. doi: 10.1016/j.bone.2015.02.002. Epub 2015 Feb 10.

PMID:
25680341
6.

An open-label, multicenter, phase 2a study to assess the feasibility of imaging metastases in late-stage cancer patients with the alpha v beta 3-selective angiogenesis imaging agent 99mTc-NC100692.

Axelsson R, Bach-Gansmo T, Castell-Conesa J, McParland BJ; Study Group.

Acta Radiol. 2010 Feb;51(1):40-6. doi: 10.3109/02841850903273974.

PMID:
20001475
7.

Validation of intratracheal instillation of lung tumour cells in mice using single photon emission computed tomography/computed tomography imaging.

Buckle T, van Leeuwen FW.

Lab Anim. 2010 Jan;44(1):40-5. doi: 10.1258/la.2009.009030. Epub 2009 Oct 23.

PMID:
19854758
8.

Development of a Radiolabeled Peptide-Based Probe Targeting MT1-MMP for Breast Cancer Detection.

Min K, Ji B, Zhao M, Ji T, Chen B, Fang X, Ma Q.

PLoS One. 2015 Oct 5;10(10):e0139471. doi: 10.1371/journal.pone.0139471. eCollection 2015.

9.

Pre-clinical Evaluation of a Cyanine-Based SPECT Probe for Multimodal Tumor Necrosis Imaging.

Stammes MA, Knol-Blankevoort VT, Cruz LJ, Feitsma HR, Mezzanotte L, Cordfunke RA, Sinisi R, Dubikovskaya EA, Maeda A, DaCosta RS, Bierau K, Chan A, Kaijzel EL, Snoeks TJ, van Beek ER, Löwik CW.

Mol Imaging Biol. 2016 Dec;18(6):905-915.

10.

Multi-Modal Imaging in a Mouse Model of Orthotopic Lung Cancer.

Patel P, Kato T, Ujiie H, Wada H, Lee D, Hu HP, Hirohashi K, Ahn JY, Zheng J, Yasufuku K.

PLoS One. 2016 Sep 1;11(9):e0161991. doi: 10.1371/journal.pone.0161991. eCollection 2016.

11.

Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects.

Munley MT, Marks LB, Scarfone C, Sibley GS, Patz EF Jr, Turkington TG, Jaszczak RJ, Gilland DR, Anscher MS, Coleman RE.

Lung Cancer. 1999 Feb;23(2):105-14.

PMID:
10217614
12.

The added value of hybrid ventilation/perfusion SPECT/CT in patients with stable COPD or apparently healthy smokers. Cancer-suspected CT findings in the lungs are common when hybrid imaging is used.

Jögi J, Markstad H, Tufvesson E, Bjermer L, Bajc M.

Int J Chron Obstruct Pulmon Dis. 2014 Dec 18;10:25-30. doi: 10.2147/COPD.S73423. eCollection 2015.

13.

Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.

Sampath L, Kwon S, Ke S, Wang W, Schiff R, Mawad ME, Sevick-Muraca EM.

J Nucl Med. 2007 Sep;48(9):1501-10.

14.

Multimodality imaging of IL-18--binding protein-Fc therapy of experimental lung metastasis.

Cao Q, Cai W, Niu G, He L, Chen X.

Clin Cancer Res. 2008 Oct 1;14(19):6137-45. doi: 10.1158/1078-0432.CCR-08-0049.

15.

Detection of Micrometastases Using SPECT/Fluorescence Dual-Modality Imaging in a CEA-Expressing Tumor Model.

Hekman MCH, Rijpkema M, Bos DL, Oosterwijk E, Goldenberg DM, Mulders PFA, Boerman OC.

J Nucl Med. 2017 May;58(5):706-710. doi: 10.2967/jnumed.116.185470. Epub 2017 Jan 26.

PMID:
28126888
16.

Evaluation of the therapeutic and diagnostic effects of PEGylated liposome-embedded 188Re on human non-small cell lung cancer using an orthotopic small-animal model.

Lin LT, Chang CH, Yu HL, Liu RS, Wang HE, Chiu SJ, Chen FD, Lee TW, Lee YJ.

J Nucl Med. 2014 Nov;55(11):1864-70. doi: 10.2967/jnumed.114.140418. Epub 2014 Oct 27.

18.

Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.

Lütje S, Rijpkema M, Franssen GM, Fracasso G, Helfrich W, Eek A, Oyen WJ, Colombatti M, Boerman OC.

J Nucl Med. 2014 Jun;55(6):995-1001. doi: 10.2967/jnumed.114.138180. Epub 2014 Apr 3.

19.

Longitudinal live animal micro-CT allows for quantitative analysis of tumor-induced bone destruction.

Johnson LC, Johnson RW, Munoz SA, Mundy GR, Peterson TE, Sterling JA.

Bone. 2011 Jan;48(1):141-51. doi: 10.1016/j.bone.2010.05.033. Epub 2010 Jun 1.

20.

Pretargeted dual-modality immuno-SPECT and near-infrared fluorescence imaging for image-guided surgery of prostate cancer.

Lütje S, Rijpkema M, Goldenberg DM, van Rij CM, Sharkey RM, McBride WJ, Franssen GM, Frielink C, Helfrich W, Oyen WJ, Boerman OC.

Cancer Res. 2014 Nov 1;74(21):6216-23. doi: 10.1158/0008-5472.CAN-14-0594. Epub 2014 Sep 24.

Supplemental Content

Support Center